Danielle M Greenawalt

Title: The Innovative Contributions of Danielle M Greenawalt

Introduction

Danielle M Greenawalt is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer treatment, particularly through her innovative methods involving anti-PD-1 antibodies. With a total of 2 patents to her name, her work is paving the way for advancements in oncology.

Latest Patents

Danielle's latest patents focus on methods of treating tumors using an anti-PD-1 antibody. This disclosure provides a method for treating a subject afflicted with a tumor, which comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from non-small cell lung cancer (NSCLC). Additionally, the tumor may express Programmed Death Ligand 1, and the subject may carry a wild-type STK11 gene.

Career Highlights

Danielle is currently employed at Bristol-Myers Squibb Company, where she continues to develop her groundbreaking research. Her work is instrumental in advancing therapeutic options for patients suffering from various types of cancer.

Collaborations

Danielle collaborates with notable colleagues, including Robin Edwards and William J Geese, who contribute to her research efforts and enhance the impact of her innovations.

Conclusion

Danielle M Greenawalt's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work not only showcases her expertise but also represents a significant step forward in the fight against cancer.